InvestorsHub Logo

hope4patients

03/08/18 6:24 PM

#161635 RE: canis_star #161632

Yep, because "patients are living much longer than expected" according to the very well respected doctors associated with this trial! :)

This is GBM btw.

survivor1x

03/08/18 7:02 PM

#161650 RE: canis_star #161632

Well,

It is an immunotherapy and the FDA has specifically warned against stopping these trials too early. Also you can't really count from 2007. 2012 is a better starting point. Still a long trial but it has only been 2.3 years since the last patient was enrolled and around 80 or so are less than 3 years from enrollment.